BIODESIX INC - Common Stock, par value $0.001 per share (BDSX)

CUSIP: 09075X207

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
9,724,771
Total 13F shares
1,148,993
Share change
+1,148,993
Total reported value
$8,674,797
Price per share
$7.55
Number of holders
25
Value change
+$8,674,797
Number of buys
25

Quarterly Holders Quick Answers

What is CUSIP 09075X207?
CUSIP 09075X207 identifies BDSX - BIODESIX INC - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of BDSX - BIODESIX INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Jack W. Schuler
13D/G
SCHULER JACK W
26%
39,821,357
$16,326,756 +$1,430,233 29 Aug 2025
Telemark Asset Management, LLC
13F
Company
79%
8,282,490
$2,337,319 30 Jun 2025
13F
Wilmington Savings Fund Society, FSB
13F
Company
58%
6,095,034
$1,720,019 30 Jun 2025
13F
Birchview Capital, LP
13F
Company
55%
5,736,113
$1,618,731 30 Jun 2025
13F
VANGUARD GROUP INC
13F
Company
36%
3,793,368
$1,069,730 30 Jun 2025
13F
PERCEPTIVE ADVISORS LLC
13F
Company
21%
2,173,880
$613,034 30 Jun 2025
13F
Monashee Investment Management LLC
13F
Company
19%
2,000,000
$564,400 30 Jun 2025
13F
Charles M. Watts
3/4/5
Director
mixed-class rows
458,755
mixed-class rows
$389,740 31 Mar 2025
SILVERARC CAPITAL MANAGEMENT, LLC
13F
Company
10%
1,070,367
$302,058 30 Jun 2025
13F
PERKINS CAPITAL MANAGEMENT INC
13F
Company
10%
1,059,711
$299,050 30 Jun 2025
13F
GSA CAPITAL PARTNERS LLP
13F
Company
8.9%
931,394
$263,000 30 Jun 2025
13F
BALYASNY ASSET MANAGEMENT L.P.
13F
Company
8.2%
859,524
$242,558 30 Jun 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
7.1%
750,877
$211,958 30 Jun 2025
13F
BlackRock, Inc.
13F
Company
4.7%
489,331
$138,089 30 Jun 2025
13F
STATE STREET CORP
13F
Company
2.9%
308,050
$86,932 30 Jun 2025
13F
Shay Capital LLC
13F
Company
2.2%
231,002
$65,189 30 Jun 2025
13F
XTX Topco Ltd
13F
Company
2%
205,647
$58,034 30 Jun 2025
13F
Cannell & Spears LLC
13F
Company
2%
205,605
$58,022 30 Jun 2025
13F
STEPHENS INC /AR/
13F
Company
1.9%
197,917
$55,852 30 Jun 2025
13F
Ryan H. Siurek
3/4/5
Chief Accounting Officer
mixed-class rows
43,825
mixed-class rows
$53,711 08 May 2023
NORTHERN TRUST CORP
13F
Company
1.6%
169,132
$47,729 30 Jun 2025
13F
Robert William Georgantas III
3/4/5
Chief Scientific Officer
class O/S missing
38,214
$46,836 21 Nov 2022
HighTower Advisors, LLC
13F
Company
1.5%
159,267
$44,945 30 Jun 2025
13F
BLAIR WILLIAM & CO/IL
13F
Company
1.3%
141,100
$39,818 30 Jun 2025
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
1.3%
137,011
$38,665 30 Jun 2025
13F
FARALLON CAPITAL MANAGEMENT LLC
13F
Company
1.2%
128,000
$36,122 30 Jun 2025
13F
Allworth Financial LP
13F
Company
0.94%
99,331
$28,032 30 Jun 2025
13F
Nantahala Capital Management, LLC
13F
Company
0.81%
84,903
$23,960 30 Jun 2025
13F
Ferguson Shapiro LLC
13F
Company
0.66%
69,096
$19,499 30 Jun 2025
13F
Corient Private Wealth LLC
13F
Company
0.56%
58,975
$16,643 30 Jun 2025
13F
Vanguard Personalized Indexing Management, LLC
13F
Company
0.4%
41,909
$11,827 30 Jun 2025
13F
CIBC Private Wealth Group LLC
13F
Company
0.28%
29,337
$8,279 30 Jun 2025
13F
Tower Research Capital LLC (TRC)
13F
Company
0.27%
28,667
$8,090 30 Jun 2025
13F
Samjo Management, LLC
13F
Company
0.24%
25,000
$7,055 30 Jun 2025
13F
Cubist Systematic Strategies, LLC
13F
Company
0.14%
14,346
$4,048 30 Jun 2025
13F
Bank of New York Mellon Corp
13F
Company
0.13%
14,002
$3,951 30 Jun 2025
13F
Carnegie Investment Counsel
13F
Company
0.1%
10,000
$2,822 30 Jun 2025
13F
Cetera Investment Advisers
13F
Company
0.1%
10,000
$2,822 30 Jun 2025
13F
MORGAN STANLEY
13F
Company
0.01%
1,278
$361 30 Jun 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.01%
753
$212 30 Jun 2025
13F
BARCLAYS PLC
13F
Company
0%
180
$51 30 Jun 2025
13F
CITIGROUP INC
13F
Company
0%
77
$22 30 Jun 2025
13F
FMR LLC
13F
Company
0%
27
$8 30 Jun 2025
13F
UBS Group AG
13F
Company
0%
22
$6 30 Jun 2025
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0%
6
$2 30 Jun 2025
13F

Institutional Holders of BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) as of Q3 2025

As of 30 Sep 2025, BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) was held by 25 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,148,993 shares. The largest 10 holders included Telemark Asset Management, LLC, VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, Monashee Investment Management LLC, PERKINS CAPITAL MANAGEMENT INC, SILVERARC CAPITAL MANAGEMENT, LLC, GSA CAPITAL PARTNERS LLP, Balyasny Asset Management L.P., GEODE CAPITAL MANAGEMENT, LLC, and BlackRock, Inc.. This page lists 25 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2025 vs Q4 2025 Across Filers

Q4 2025 holders
25
Q3 2025 holders
25
Holder diff
0
Investor Q4 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q4 2025 Value $ Q3 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .